drugset / Trial / NCT00184977
COPD on Primary Care Treatment (COOPT)
Phase 4
Completed
270 enrolled
Radboud University Medical Center
Dutch Health Care Insurance Board · collabGlaxoSmithKline · collabThe Netherlands Asthma Foundation · collabZambon SpA · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
The aim of this family practice based study is to determine the long-term treatment effects of two drugs that are presumed to modify the course and progression of chronic obstructive pulmonary disease (COPD), oral N-acetylcysteine and inhaled corticosteroids.
Timeline
- Start
- 1998-12
- Primary completion
- —
- Completion
- 2003-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fluticasone propionate | Other / unclassified | 500 ug | Inhaled |
| Subject | N-acetylcysteine | Small molecule | 600 mg | — |